Source: Current Eye Research. Unidade: FMRP
Subjects: ADENOVIRIDAE, CERATOCONJUNTIVITE ANIMAL, ERITROPOIETINA, APARELHO LACRIMAL, DIAGNÓSTICO POR IMAGEM
ABNT
DIAS, Lara Cristina et al. Lacrimal gland as a target organ for adenovirus gene therapy encoding erythropoietin for dry eye induced by benzalkonium chloride. Current Eye Research, v. 46, n. 9, p. 1314-1319, 2021Tradução . . Disponível em: https://doi.org/10.1080/02713683.2021.1893754. Acesso em: 15 nov. 2024.APA
Dias, L. C., Zheng, C., Murashima, A. de A. B., Dias, A. C., Fantucci, M. Z., Nominato, L. F., et al. (2021). Lacrimal gland as a target organ for adenovirus gene therapy encoding erythropoietin for dry eye induced by benzalkonium chloride. Current Eye Research, 46( 9), 1314-1319. doi:10.1080/02713683.2021.1893754NLM
Dias LC, Zheng C, Murashima A de AB, Dias AC, Fantucci MZ, Nominato LF, Silva LECM da, Rocha EM. Lacrimal gland as a target organ for adenovirus gene therapy encoding erythropoietin for dry eye induced by benzalkonium chloride [Internet]. Current Eye Research. 2021 ; 46( 9): 1314-1319.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1080/02713683.2021.1893754Vancouver
Dias LC, Zheng C, Murashima A de AB, Dias AC, Fantucci MZ, Nominato LF, Silva LECM da, Rocha EM. Lacrimal gland as a target organ for adenovirus gene therapy encoding erythropoietin for dry eye induced by benzalkonium chloride [Internet]. Current Eye Research. 2021 ; 46( 9): 1314-1319.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1080/02713683.2021.1893754